Optical Coherence Tomography in Staging Patients With Upper Tract Urothelial Cancer
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
This clinical trial studies how well optical coherence tomography works in staging patients with upper-tract urothelial carcinomas. Staging describes the severity of a person's cancer based on the size and/or extent (reach) of the original (primary) tumor and whether or not cancer has spread in the body. It also helps the doctor plan the appropriate treatment. Optical coherence tomography is a procedure that uses infrared light waves to give three-dimensional pictures of structures inside tissues and organs. The pictures are made by a computer linked to the light source. Optical coherence tomography may be effective in staging patients with upper-tract urothelial carcinomas.
Full description
PRIMARY OBJECTIVES:
I. To test the feasibility and imaging ability of optical coherence tomography (OCT) to stage upper-tract urothelial carcinomas (UTUC).
OUTLINE:
Patients undergo optical coherence tomography over 10-15 minutes.
After completion of study, patients are followed up at 3 months.
Sex
Ages
Volunteers
Inclusion criteria
- Patients must have radiographic evidence of upper tract urothelial cancer by computed tomography (CT), magnetic resonance imaging (MRI) or intravenous pyelogram (IVP) in order to undergo this procedure
- Patient who will undergo standard of care clinical staging for UTUC
- Patient ability to read and comprehend the informed consent document
Exclusion criteria
- Patient who has a contraindication to endoscopy
- Patient who is pregnant
Trial design
Primary purpose
Allocation
Interventional model
Masking
0 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal